The Food and Drug Administration (FDA) has approved Breo Ellipta (fluticasone furoate/vilanterol) for the once-daily treatment of asthma in patients aged 18 years and older. The approval of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback